Insights

Modular Automation Value Celltrio’s modular cell culturing automation platform enables scalable, phased investment from initial task modules to full robotics and software integration, presenting a clear upsell path for labs aiming to expand capabilities while reducing manual processes.

Time-to-Market Advantage The emphasis on reducing drug or novel cell development time-to-market through automated, repeatable processes highlights a compelling value proposition for biotech and pharma customers seeking faster product pipelines and competitive differentiation.

Precision and Quality Automation designed to minimize human and system errors offers a strong selling point to labs prioritizing data integrity, compliance, and consistent yields, which can translate into longer-term contracts and higher customer satisfaction.

Cryogenic and Storage Synergy Celltrio’s mention of cryogenic freezer solutions alongside culturing automation suggests cross-sell opportunities to customers needing end-to-end workflow automation, from storage to automated processing.

Growth and Funding Readiness With a revenue range of 10–25 million and 15 million in funding, target customers in mid-to-large biotech segments may be receptive to scale-up partnerships, integration services, and larger multi-module deployments that align with Celltrio’s roadmap.

Similar companies to Celltrio

Celltrio Tech Stack

Celltrio uses 8 technology products and services including Wix, WordPress, Microsoft 365, and more. Explore Celltrio's tech stack below.

  • Content Management System
  • Content Management System
  • Infrastructure As A Service
  • Marketing Automation
  • X-Content-Type-Options
    Web & Portal Technology
  • Google Analytics
    Web Analytics
  • Ninja Forms
    Web Platform Extensions

Celltrio's Email Address Formats

Celltrio uses at least 1 email format:
Celltrio Email FormatsExamplePercentage
First.Last@celltrio.comJohn.Doe@celltrio.com
100%

Frequently Asked Questions

What is Celltrio's stock symbol?

Minus sign iconPlus sign icon
Celltrio is a publicly traded company; the company's stock symbol is 068270.KS.

What is Celltrio's official website and social media links?

Minus sign iconPlus sign icon
Celltrio's official website is celltrio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Celltrio generate?

Minus sign iconPlus sign icon
As of November 2026, Celltrio's annual revenue is estimated to be $10M - $25M.

What is Celltrio's SIC code and NAICS code?

Minus sign iconPlus sign icon
Celltrio's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Celltrio have currently?

Minus sign iconPlus sign icon
As of November 2026, Celltrio has approximately 36 employees across 1 continents, including North America. Key team members include Vice President Of Product Management, Celltrio: J. H., Fractional Cfo, Head Of Finance: B. S. and Corporate Controller: C. C. Explore Celltrio's employee directory with LeadIQ.

What industry does Celltrio belong to?

Minus sign iconPlus sign icon
Celltrio operates in the Biotechnology Research industry.

What technology does Celltrio use?

Minus sign iconPlus sign icon
Celltrio's tech stack includes Wix, WordPress, Microsoft 365, Google Cloud, HubSpot, X-Content-Type-Options, Google Analytics and Ninja Forms.

What is Celltrio's email format?

Minus sign iconPlus sign icon
Celltrio's email format typically follows the pattern of First.Last@celltrio.com. Find more Celltrio email formats with LeadIQ.

How much funding has Celltrio raised to date?

Minus sign iconPlus sign icon
As of November 2026, Celltrio has raised $15M in funding. The last funding round occurred on Jun 17, 2025 for $15M.

When was Celltrio founded?

Minus sign iconPlus sign icon
Celltrio was founded in 2018.
Celltrio logo

Celltrio

Biotechnology ResearchCalifornia, United States11-50 Employees

Celltrio is a biotechnology research company based in Fremont, California, focused on automating cell culturing workflows. Its approach centers on modular stand-alone machines and software that can be assembled into customizable lab automation solutions, allowing labs to start with a small set of task modules and scale up as needed. By integrating manual cell storage, culturing, and harvesting processes with automated robot-enabled capabilities, Celltrio aims to reduce time-to-market for drug or novel cell development while lowering equipment, training, labor, and total costs, and improving precision and quality through reduced human error. The company targets laboratories seeking modular, scalable automation tailored to their specific cell culturing protocols, offering both automated systems and cryogenic freezer solutions. Celltrio operates in the biotechnology research industry with a focus on providing end-to-end automation that can adapt to evolving laboratory needs.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
068270.KS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $15M

    Celltrio has raised a total of $15M of funding over 1 rounds. Their latest funding round was raised on Jun 17, 2025 in the amount of $15M as a Venture Round.

  • $10M - $25M

    Celltrio's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.